Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Gerber has grown skeptical of Musk's other ventures in recent years, and has said previously that his side projects are ...

Jared Cohen, Goldman Sachs president of global affairs, co-head of the Goldman Sachs Global Institute, said while talking to ...

Wedbush has an outperform rating on Apple's stock heading into the holiday season and a 12-month price target of $300, that's about 28% above its current price. It's the highest price target among the ...

For some, Black Friday kicks off the holiday shopping season, a period of time that Apple (NASDAQ:AAPL) is heavily dependent ...

Tesla Inc.'s stock rose 1.8% Friday, after Wedbush analyst Dan Ives' published his latest bullish note on the EV maker, predicting that the artificial intelligence and autonomous driving opportunity ...

Gary Black of The Future Fund LLC confirmed that Tesla's Cybercab won't launch until 2026, dismissing early rollout rumors, ...

Artificial intelligence (AI) has defined the investment narrative of 2024, and Palantir Technologies Inc. (PLTR) has emerged ...

US stocks closed at record highs on Friday, with the Dow Jones Industrial Average ( ^DJI) rising 0.4% to close at a record high and the S&P 500 ( ^GSPC) gaining 0.6% to reach a record at the end of a ...

These 3 iPad Pro Features Should Come to the iPhone ...